NM_172351.3:c.70A>T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_172351.3(CD46):​c.70A>T​(p.Met24Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M24V) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

CD46
NM_172351.3 missense

Scores

19

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.37

Publications

0 publications found
Variant links:
Genes affected
CD46 (HGNC:6953): (CD46 molecule) The protein encoded by this gene is a type I membrane protein and is a regulatory part of the complement system. The encoded protein has cofactor activity for inactivation of complement components C3b and C4b by serum factor I, which protects the host cell from damage by complement. In addition, the encoded protein can act as a receptor for the Edmonston strain of measles virus, human herpesvirus-6, and type IV pili of pathogenic Neisseria. Finally, the protein encoded by this gene may be involved in the fusion of the spermatozoa with the oocyte during fertilization. Mutations at this locus have been associated with susceptibility to hemolytic uremic syndrome. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jun 2010]
CD46 Gene-Disease associations (from GenCC):
  • atypical hemolytic-uremic syndrome with MCP/CD46 anomaly
    Inheritance: AD, AR, SD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.022499591).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CD46NM_172351.3 linkc.70A>T p.Met24Leu missense_variant Exon 1 of 13 ENST00000367042.6 NP_758861.1 P15529-11

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CD46ENST00000367042.6 linkc.70A>T p.Met24Leu missense_variant Exon 1 of 13 1 NM_172351.3 ENSP00000356009.1 P15529-11

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000796
AC:
2
AN:
251364
AF XY:
0.00000736
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000205
AC:
3
AN:
1461786
Hom.:
0
Cov.:
31
AF XY:
0.00000138
AC XY:
1
AN XY:
727218
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33476
American (AMR)
AF:
0.0000671
AC:
3
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53378
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111972
Other (OTH)
AF:
0.00
AC:
0
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
ExAC
AF:
0.00000824
AC:
1

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.0090
DANN
Benign
0.35
DEOGEN2
Benign
0.088
T;.;.;.;.;.;.;.;.;.
Eigen
Benign
-2.3
Eigen_PC
Benign
-2.3
FATHMM_MKL
Benign
0.040
N
LIST_S2
Benign
0.35
T;T;T;T;T;T;T;T;T;T
M_CAP
Benign
0.0057
T
MetaRNN
Benign
0.022
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-2.0
N;N;N;N;N;N;N;N;N;N
PhyloP100
-2.4
PrimateAI
Benign
0.28
T
PROVEAN
Benign
1.0
N;N;N;N;N;N;N;N;N;N
REVEL
Benign
0.0090
Sift
Benign
1.0
T;T;T;T;T;T;T;T;T;T
Sift4G
Benign
1.0
T;T;T;T;T;T;T;T;T;T
Polyphen
0.0
B;B;B;B;B;B;B;.;B;B
Vest4
0.058
MutPred
0.52
Loss of phosphorylation at Y29 (P = 0.1507);Loss of phosphorylation at Y29 (P = 0.1507);Loss of phosphorylation at Y29 (P = 0.1507);Loss of phosphorylation at Y29 (P = 0.1507);Loss of phosphorylation at Y29 (P = 0.1507);Loss of phosphorylation at Y29 (P = 0.1507);Loss of phosphorylation at Y29 (P = 0.1507);Loss of phosphorylation at Y29 (P = 0.1507);Loss of phosphorylation at Y29 (P = 0.1507);Loss of phosphorylation at Y29 (P = 0.1507);
MVP
0.048
MPC
0.14
ClinPred
0.064
T
GERP RS
-6.4
PromoterAI
-0.46
Neutral
Varity_R
0.13
gMVP
0.33
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs750342865; hg19: chr1-207925627; API